Biomatics Capital Partners

Summary

In 2016 was created Biomatics Capital Partners, which is appeared as VC. The main office of represented VC is situated in the Seattle. The company was established in North America in United States.

The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Biomatics Capital Partners, startups are often financed by ARCH Venture Partners, Venrock, Asset Management Ventures (AMV). The meaningful sponsors for the fund in investment in the same round are GV, Tribeca Venture Partners, Pritzker Group Venture Capital. In the next rounds fund is usually obtained by ARCH Venture Partners, Tribeca Venture Partners, Sequoia Capital China.

This Biomatics Capital Partners works on 16 percentage points less the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2018. The top amount of exits for fund were in 2019. The fund is constantly included in 2-6 investment rounds annually. The usual things for fund are deals in the range of 50 - 100 millions dollars. Considering the real fund results, this VC is 11 percentage points more often commits exit comparing to other organizations.

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Health Care, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline GRAIL, Denali Therapeutics, Verve Therapeutics

This organization was formed by Boris Nikolic, Julie Sunderland. Besides them, we counted 1 critical employee of this fund in our database.